BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 12827274)

  • 1. Peptide-mediated cellular delivery of antisense oligonucleotides and their analogues.
    Gait MJ
    Cell Mol Life Sci; 2003 May; 60(5):844-53. PubMed ID: 12827274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoplex and peptide-based strategies for the delivery of steric-block oligonucleotides.
    Resina S; Abes S; Turner JJ; Prevot P; Travo A; Clair P; Gait MJ; Thierry AR; Lebleu B
    Int J Pharm; 2007 Nov; 344(1-2):96-102. PubMed ID: 17600642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular delivery of peptide nucleic acid by cell-penetrating peptides.
    Kilk K; Langel U
    Methods Mol Biol; 2005; 298():131-41. PubMed ID: 16044544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell penetrating peptide conjugates of steric block oligonucleotides.
    Lebleu B; Moulton HM; Abes R; Ivanova GD; Abes S; Stein DA; Iversen PL; Arzumanov AA; Gait MJ
    Adv Drug Deliv Rev; 2008 Mar; 60(4-5):517-29. PubMed ID: 18037527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear localization and antisense effect of PNA internalized by ASGP-R-mediated endocytosis with protein/DNA conjugates.
    Ishihara T; Kano A; Obara K; Saito M; Chen X; Park TG; Akaike T; Maruyama A
    J Control Release; 2011 Oct; 155(1):34-9. PubMed ID: 20955741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PNA-based antisense oligonucleotides for micrornas inhibition in the absence of a transfection reagent.
    Oh SY; Ju Y; Kim S; Park H
    Oligonucleotides; 2010 Oct; 20(5):225-30. PubMed ID: 20946011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flavin conjugates for delivery of peptide nucleic acids.
    Marlin F; Simon P; Bonneau S; Alberti P; Cordier C; Boix C; Perrouault L; Fossey A; Saison-Behmoaras T; Fontecave M; Giovannangeli C
    Chembiochem; 2012 Nov; 13(17):2593-8. PubMed ID: 23129496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting Cancer Gene Dependencies with Anthrax-Mediated Delivery of Peptide Nucleic Acids.
    Lu Z; Paolella BR; Truex NL; Loftis AR; Liao X; Rabideau AE; Brown MS; Busanovich J; Beroukhim R; Pentelute BL
    ACS Chem Biol; 2020 Jun; 15(6):1358-1369. PubMed ID: 32348107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved cellular uptake of antisense peptide nucleic acids by conjugation to a cell-penetrating peptide and a lipid domain.
    Shiraishi T; Nielsen PE
    Methods Mol Biol; 2011; 751():209-21. PubMed ID: 21674333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A non-covalent peptide-based strategy for ex vivo and in vivo oligonucleotide delivery.
    Crombez L; Morris MC; Heitz F; Divita G
    Methods Mol Biol; 2011; 764():59-73. PubMed ID: 21748633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective exon skipping and restoration of dystrophin expression by peptide nucleic acid antisense oligonucleotides in mdx mice.
    Yin H; Lu Q; Wood M
    Mol Ther; 2008 Jan; 16(1):38-45. PubMed ID: 17968354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A non-covalent peptide-based carrier for in vivo delivery of DNA mimics.
    Morris MC; Gros E; Aldrian-Herrada G; Choob M; Archdeacon J; Heitz F; Divita G
    Nucleic Acids Res; 2007; 35(7):e49. PubMed ID: 17341467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incorporation of Naked Peptide Nucleic Acids into Liposomes Leads to Fast and Efficient Delivery.
    Avitabile C; Accardo A; Ringhieri P; Morelli G; Saviano M; Montagner G; Fabbri E; Gallerani E; Gambari R; Romanelli A
    Bioconjug Chem; 2015 Aug; 26(8):1533-41. PubMed ID: 26176882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview of alternative oligonucleotide chemistries for exon skipping.
    Saleh AF; Arzumanov AA; Gait MJ
    Methods Mol Biol; 2012; 867():365-78. PubMed ID: 22454073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delivery of antisense peptide nucleic acids to cells by conjugation with small arginine-rich cell-penetrating peptide (R/W)9.
    Cordier C; Boutimah F; Bourdeloux M; Dupuy F; Met E; Alberti P; Loll F; Chassaing G; Burlina F; Saison-Behmoaras TE
    PLoS One; 2014; 9(8):e104999. PubMed ID: 25127364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell number and transfection volume dependent peptide nucleic acid antisense activity by cationic delivery methods.
    Llovera L; Berthold P; Nielsen PE; Shiraishi T
    Artif DNA PNA XNA; 2012; 3(1):22-7. PubMed ID: 22679530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conjugates of oligonucleotides and analogues with cell penetrating peptides as gene silencing agents.
    Zatsepin TS; Turner JJ; Oretskaya TS; Gait MJ
    Curr Pharm Des; 2005; 11(28):3639-54. PubMed ID: 16305500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delivery of cell-penetrating peptide-peptide nucleic acid conjugates by assembly on an oligonucleotide scaffold.
    Zhao XL; Chen BC; Han JC; Wei L; Pan XB
    Sci Rep; 2015 Nov; 5():17640. PubMed ID: 26612536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uptake, Stability, and Activity of Antisense Anti-
    Yavari N; Goltermann L; Nielsen PE
    ACS Chem Biol; 2021 Mar; 16(3):471-479. PubMed ID: 33684286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vectorization of morpholino oligomers by the (R-Ahx-R)4 peptide allows efficient splicing correction in the absence of endosomolytic agents.
    Abes S; Moulton HM; Clair P; Prevot P; Youngblood DS; Wu RP; Iversen PL; Lebleu B
    J Control Release; 2006 Dec; 116(3):304-13. PubMed ID: 17097177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.